Skip to main content
Veterinary Medicines

PENTOMAST LC, intramaminė suspensija galvijams

Authorised
  • Prednisolone
  • NEOMYCIN SULFATE
  • Streptomycin sulfate
  • Benzylpenicillin procaine

Product identification

Medicine name:
PENTOMAST LC, intramaminė suspensija galvijams
Active substance:
  • Prednisolone
  • NEOMYCIN SULFATE
  • Streptomycin sulfate
  • Benzylpenicillin procaine
Target species:
  • Cattle (cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Prednisolone
    10.00
    milligram(s)
    /
    1.00
    Syringe
  • NEOMYCIN SULFATE
    100.00
    milligram(s)
    /
    1.00
    Syringe
  • Streptomycin sulfate
    100.00
    milligram(s)
    /
    1.00
    Syringe
  • Benzylpenicillin procaine
    100000.00
    international unit(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (cow)
      • Milk
        108
        hour
      • Meat and offal
        7
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RV01
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Interchemie werken De Adelaar LT UAB
Marketing authorisation date:
Manufacturing sites for batch release:
  • Interchemie Werken De Adelaar Eesti AS
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/18/2447/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 19/03/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."